Please login to the form below

gene-editing

This page shows the latest gene-editing news and features for those working in and with pharma, biotech and healthcare.

Gilead drug reduces HIV viral reservoir, says researcher

Nevertheless, it has encouraged research into therapies that might help patients, such as using gene-editing drugs to splice resistance genes into white blood cells.

Latest news

Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal

Biogen has made another big investment play in Alzheimer’s disease, penning a $350m upfront agreement with gene-editing specialist Sangamo for rights to tau-targeting drug ST-501 as part ... Sangamo’s specialises in the development of gene-editing
Policy and public health: all the decisions we can't see

In the case of He Jiankui, many countries have policies and laws in place against germline gene editing.
CRISPR gene-editing in cancer patients is safe, according to new study

The researchers of the new study took a different route with their method of gene-editing. ... In November last year, Vertex and CRISPR Therapeutics revealed initial positive data from the first two patients treated with their investigational CRISPR/Cas9
The year in review

This past year also brought us more news on the gene-editing front. ... And then came the news in October that Russian biologist Denis Rebrikov has started gene editing using eggs donated by women who can hear, to learn how to allow some deaf
Bluebird bio’s sickle cell gene therapy shows early-study benefit

When patients have copies of the functional gene, their red blood cells can produce anti-sickling haemoglobin which decreases the amount of the faulty sickled haemoglobin. ... The partners recently revealed initial positive data from the first two

More from news
Approximately 6 fully matching, plus 47 partially matching documents found.

Latest Intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’

The next phases were to enrich the pipeline with acquisitions and partnerships, including a headline deal with blue-bird bio for next generation gene editing that could lead to a potential ... We also have a stem cell platform, gene editing, an exquisite
It started with a miss

There are huge implications for communications. Take gene editing, for example. ... We’re going to get to the point where treatments like gene therapies will be ubiquitous – so we need to set ourselves up for them now and embrace the ethical debate
Bluebird: on a mission to ‘recode’ the DNA of healthcare

Europe is the test ground for the gene therapy pioneer’s outcomes-based model, which could set the standard for the emerging sector. ... These include pipeline gene-editing therapies from Sanofi and luspatercept from Celgene to name but a few, although
Vertex: a vision of treating all CF patients worldwide draws closer

A gene therapy cure for all the world’s CF patients would be a truly remarkable achievement. ... These include alpha-1 antitrypsin deficiency and focal segmental glomerulosclerosis. It’s also working with CRISPR Therapeutics on phase 1/2 clinical
2019: CRISPR and therapeutic gene editing comes of age

Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases? ... Meanwhile, CRISPR isn’t the only gene-editing technology being used in human therapeutics, although its devotees claim it is the simplest, easiest and

More from intelligence
Approximately 2 fully matching, plus 13 partially matching documents found.

Latest appointments

Eric Rhodes becomes CEO of ERS Genomics

In these roles, Rhodes was responsible for commercialising the company's genome editing technologies as well as driving its research and development. ... Biosciences. Foy said: “With his deep understanding of the gene-editing landscape and extensive
Marc Becker joins CRISPR Therapeutics

He becomes chief financial officer. CRISPR Therapeutics has appointed Marc Becker as its new chief financial officer with remit to drive development of its gene-editing technology platform.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Spotlight interview: 15 minutes on medical and scientific writing

A number of current therapeutic approaches – such as gene editing, gene therapy, and stem-cell therapy – were not in existence when many healthcare professionals (HCPs) underwent their training, so there is
'Fake news': battling misinformation in healthcare

After reading this headline, it’s easy to assume that some form of gene editing has led to a cure for HIV. ... Should you read on, you would also discover that gene-editing was in no way used in this treatment.
Random42 Partner with MedCity for BioJapan 2018

J. Leading UK health scientists, universities and national research institutions will provide insight into the UK life sciences sector, and their work in ageing, gene editing and artificial intelligence.
Training the next generation of biotech leaders

Novel technologies, coupled with programmes designed to drive cell and gene research and development, are ushering in a new era of therapies. ... It’s such a disruptive advancement – it’s just incredible to think it has all been made feasible
Perspective on biotech

The emerging technologies revolutionising the biotech industry – from immunotherapy breakthroughs to cutting-edge gene editing techniques.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Account Director – UK Office: Excellent salary and benefits

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Account Manager (PR): Great Benefits

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Senior Account Manager: Salary TBC

Account Manager: £Competitive Salary

Senior External Communications Lead: £Competitive Salary

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Account Director: £Competitive Salary

PMHub

Add my company

W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?: Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma funding and M&A in 2020: Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?: Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...